No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
MSD Acquires EyeBio for US$3B
On 29 May 2024, Merck (MSD) announced the acquisition of privately owned opthalmology focussed biotech EyeBio for US$3 billion, including an upfront payment of US$1.3 billion and $US1.7 billion in milestone payments. The acquisition has been unanimously approved by...